Genomed Spólka Akcyjna Statistics
Total Valuation
WSE:GEN has a market cap or net worth of PLN 34.35 million. The enterprise value is 29.11 million.
Market Cap | 34.35M |
Enterprise Value | 29.11M |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
WSE:GEN has 1.32 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 1.32M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 44.76% |
Owned by Institutions (%) | n/a |
Float | 41,650 |
Valuation Ratios
The trailing PE ratio is 30.99.
PE Ratio | 30.99 |
Forward PE | n/a |
PS Ratio | 1.49 |
PB Ratio | 3.11 |
P/TBV Ratio | 3.13 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.97, with an EV/FCF ratio of -1,078.74.
EV / Earnings | 26.26 |
EV / Sales | 1.27 |
EV / EBITDA | 14.97 |
EV / EBIT | 24.24 |
EV / FCF | -1,078.74 |
Financial Position
The company has a current ratio of 6.28
Current Ratio | 6.28 |
Quick Ratio | 4.82 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 4,637.09 |
Financial Efficiency
Return on equity (ROE) is 10.50% and return on invested capital (ROIC) is 7.11%.
Return on Equity (ROE) | 10.50% |
Return on Assets (ROA) | 6.01% |
Return on Invested Capital (ROIC) | 7.11% |
Return on Capital Employed (ROCE) | 10.55% |
Revenue Per Employee | 479,310 |
Profits Per Employee | 23,092 |
Employee Count | 48 |
Asset Turnover | 1.84 |
Inventory Turnover | 4.10 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.16% in the last 52 weeks. The beta is 0.04, so WSE:GEN's price volatility has been lower than the market average.
Beta (5Y) | 0.04 |
52-Week Price Change | -12.16% |
50-Day Moving Average | 27.00 |
200-Day Moving Average | 29.43 |
Relative Strength Index (RSI) | 39.64 |
Average Volume (20 Days) | 76 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:GEN had revenue of PLN 23.01 million and earned 1.11 million in profits. Earnings per share was 0.84.
Revenue | 23.01M |
Gross Profit | 14.49M |
Operating Income | 1.20M |
Pretax Income | 1.21M |
Net Income | 1.11M |
EBITDA | 1.95M |
EBIT | 1.20M |
Earnings Per Share (EPS) | 0.84 |
Balance Sheet
The company has 5.24 million in cash and n/a in debt, giving a net cash position of 5.24 million or 3.97 per share.
Cash & Cash Equivalents | 5.24M |
Total Debt | n/a |
Net Cash | 5.24M |
Net Cash Per Share | 3.97 |
Equity (Book Value) | 11.04M |
Book Value Per Share | 8.36 |
Working Capital | 7.73M |
Cash Flow
In the last 12 months, operating cash flow was 1.64 million and capital expenditures -1.67 million, giving a free cash flow of -26,986.
Operating Cash Flow | 1.64M |
Capital Expenditures | -1.67M |
Free Cash Flow | -26,986 |
FCF Per Share | -0.02 |
Margins
Gross margin is 62.99%, with operating and profit margins of 5.22% and 4.82%.
Gross Margin | 62.99% |
Operating Margin | 5.22% |
Pretax Margin | 5.26% |
Profit Margin | 4.82% |
EBITDA Margin | 8.45% |
EBIT Margin | 5.22% |
FCF Margin | n/a |
Dividends & Yields
WSE:GEN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 3.23% |
FCF Yield | -0.08% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
WSE:GEN has an Altman Z-Score of 16.4.
Altman Z-Score | 16.4 |
Piotroski F-Score | n/a |